Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 140Esophageal Neoplasms 71Pancreatic Neoplasms 42Esophageal Squamous Cell Carcinoma 26Carcinoma, Non-Small-Cell Lung 24Adenocarcinoma Of Esophagus 23Breast Neoplasms 18Neoplasms 15Neoplasm Metastasis 15Colorectal Neoplasms 15Prostatic Neoplasms 11Ovarian Neoplasms 9Melanoma 9Squamous Cell Carcinoma of Head and Neck 8Lung Neoplasms 8Adenocarcinoma 8Sarcoma 7Colonic Neoplasms 7Biliary Tract Neoplasms 7Small Cell Lung Carcinoma 6Parkinson Disease 4, Autosomal Dominant Lewy Body 6Carcinoma, Renal Cell 6Urinary Bladder Neoplasms 5Gastrointestinal Neoplasms 5Gallbladder Neoplasms 5Carcinoma, Hepatocellular 5Uterine Cervical Neoplasms 4Salivary Gland Neoplasms 4Rectal Neoplasms 4Head and Neck Neoplasms 4

Interventions

Gemcitabine 6Fluorouracil 5Leucovorin 4Irinotecan 3Albumin-Bound Paclitaxel 3pembrolizumab 2irinotecan sucrosofate 2Oxaliplatin 24-fluorobenzoyl-TN-14003 2zolbetuximab 1regorafenib 1olaparib 1ibrutinib 1beta-D-glucosylisophosphoramide mustard 1adavosertib 1Tetrahydrouridine 1Telemedicine 1Taxes 1Practice Guidelines as Topic 1Paclitaxel 1PEGPH20 1Erlotinib Hydrochloride 1Drug Therapy 1Docetaxel 1Decitabine 1Counseling 1Cisplatin 1Capecitabine 1BKT140 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Metastatic Pancreatic Adenocarcinoma × Docetaxel × Gastrointestinal × Clear all
NCT02324543 2023-07-21

Study of Gemcitabine/Taxotere/Xeloda (GTX) in Combination With Cisplatin and Irinotecan in Subjects With Metastatic Pancreatic Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Completed
47 enrolled 22 charts
Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡